SERTAD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.885400E-01
Normal-vs-Stage2
5.157400E-01
Normal-vs-Stage3
4.290800E-01
Normal-vs-Stage4
6.035400E-01
Stage1-vs-Stage2
1.712560E-01
Stage1-vs-Stage3
6.473800E-01
Stage1-vs-Stage4
2.822400E-02
Stage2-vs-Stage3
4.391600E-01
Stage2-vs-Stage4
5.557200E-01
Stage3-vs-Stage4
1.702620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.983200E-01
Normal-vs-AfricanAmerican
5.084200E-01
Normal-vs-Asian
4.244800E-01
Caucasian-vs-AfricanAmerican
9.798400E-01
Caucasian-vs-Asian
2.759800E-01
AfricanAmerican-vs-Asian
4.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.008600E-01
Normal-vs-Female
4.879000E-01
Male-vs-Female
7.297600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.456400E-01
Normal-vs-Age(41-60Yrs)
6.007800E-01
Normal-vs-Age(61-80Yrs)
4.507000E-01
Normal-vs-Age(81-100Yrs)
4.500200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.376800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.134400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.555800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.421100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.692000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.598800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.111800E-01
Normal-vs-Daily Drinker
5.097200E-01
Normal-vs-Weekly Drinker
4.027400E-01
Normal-vs-Occasional Drinker
5.372800E-01
Normal-vs-Social Drinker
4.470200E-01
Non Drinker-vs-Daily Drinker
9.853400E-01
Non Drinker-vs-Weekly Drinker
1.602390E-01
Non Drinker-vs-Occasional Drinker
7.636800E-01
Non Drinker-vs-Social Drinker
4.177400E-01
Daily Drinker-vs-Weekly Drinker
1.374160E-01
Daily Drinker-vs-Occasional Drinker
7.425600E-01
Daily Drinker-vs-Social Drinker
3.984400E-01
Weekly Drinker-vs-Occasional Drinker
9.208400E-02
Weekly Drinker-vs-Social Drinker
5.153000E-01
Occasional Drinker-vs-Social Drinker
2.742200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.026000E-01
Normal-vs-Grade 2
2.041900E-02
Normal-vs-Grade 3
2.494100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.398500E-03
Grade 1-vs-Grade 3
7.361500E-03
Grade 1-vs-Grade 4
2.026000E-01
Grade 2-vs-Grade 3
7.087400E-01
Grade 2-vs-Grade 4
2.041900E-02
Grade 3-vs-Grade 4
2.494100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.473400E-01
Normal-vs-NonDiabetic
4.649400E-01
Diabetic-vs-NonDiabetic
7.894300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.707400E-01
Normal-vs-NoPancreatitis
4.852800E-01
Pancreatitis-vs-NoPancreatitis
1.193840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.471600E-01
Normal-vs-N1
5.196600E-01
N0-vs-N1
6.820300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.269800E-01
Normal-vs-TP53-NonMutant
3.384600E-01
TP53-Mutant-vs-TP53-NonMutant
4.970100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
